Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method in Patients With High Risk of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Multicenter Randomized Controlled Trial

NCT02916199 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.

NCT NCT02916199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02916199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method in Patients With High Risk of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Multicenter Randomized Controlled Trial
Lead sponsor
Gangnam Severance Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 4, 2016
Completion date
November 28, 2017
Enrollment
207 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

biliary stricture, common bile duct stone, malignant hepatobiliary neoplasm, pancreatic diseases, sphincter of oddi dysfunction